AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8+T cells by inducing CD103+dendritic cell-mediated T cell priming

被引:1
作者
Im, Kyungtaek [1 ]
Choi, Yun Jung [1 ]
Kim, Dong Ha [1 ]
Kim, Da -Som [2 ]
Ban, Kyosun [2 ]
Ji, Wonjun [3 ]
Baek, In-Jeoung [4 ]
Choi, Chang-Min [3 ]
Lee, Jae Cheol [5 ]
Rho, Jin Kyung [6 ,7 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Asan Inst Life Sci, Coll Med, Seoul 05505, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci,AMIST, Seoul 05505, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulmonol & Crit Care Med, Seoul 05505, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cell & Genet Engn, Seoul 05505, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul 05505, South Korea
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biochem & Mol Biol, Seoul 05505, South Korea
[7] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
基金
新加坡国家研究基金会;
关键词
AXL receptor tyrosine kinase (AXL); Dendritic cell (DC); Tumor microenvironment; Lung cancer; CD8+T cell; DENDRITIC CELLS; ACTIVATION; MACROPHAGES; EXPRESSION; RESISTANCE; RESPONSES; INVASION;
D O I
10.1016/j.bbrc.2023.09.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AXL is a member of TAM receptor family and has been highlighted as a potential target for cancer treatment. Accumulating evidence has uncovered the critical role of the AXL signaling pathway in tumor growth, metastasis, and resistance against anti-cancer drugs, as well as its association with cancer immune escape. However, the function of AXL as a manipulator of the immune system in the tumor microenvironment (TME) remains unclear. Therefore, in this study, we investigated the impact of AXL on immune cells in the TME of a syngeneic tumor model using AXL knockout (AXL-/-) mice. Compared to AXL wild-type (AXL+/+) mice, tumor growth was significantly suppressed in AXL-/- mice, and an induced population of tumor-infiltrated CD8+ T cells and CD103+ dendritic cells (DCs) was observed. The change of CD8+ T cells and CD103+ DCs was also confirmed in tumor-draining lymph nodes (TdLN). In addition, the clonal expansion of OVA-specific CD8+ T cells was dominant in AXL-/- mice. Finally, anti-PD-1 treatment evidenced synergistic anti-cancer effects in AXL-/- mice. Overall, our data indicate that AXL signaling may inhibit the clonal expansion of tumor-specific CD8+ T cells through the regulation of the migration of CD8+ T cells and DCs in TME. Thus, AXL may be a powerful molecular target to improve anti-cancer effects through single or combined therapy with immune checkpoint inhibitors (ICI).
引用
收藏
页码:7 / 14
页数:8
相关论文
共 30 条
[1]   Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination [J].
Aarntzen, Erik H. J. G. ;
De Vries, I. Jolanda M. ;
Lesterhuis, W. Joost ;
Schuurhuis, Danita ;
Jacobs, Joannes F. M. ;
Bol, Kalijn ;
Schreibelt, Gerty ;
Mus, Roel ;
De Wilt, Johannes H. W. ;
Haanen, John B. A. G. ;
Schadendorf, Dirk ;
Croockewit, Alexandra ;
Blokx, Willeke A. M. ;
Van Rossum, Michelle M. ;
Kwok, William W. ;
Adema, Gosse J. ;
Punt, Cornelis J. A. ;
Figdor, Carl G. .
CANCER RESEARCH, 2013, 73 (01) :19-29
[2]   MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma [J].
Bell, Jonathan B. ;
Eckerdt, Frank D. ;
Alley, Kristen ;
Magnusson, Lisa P. ;
Hussain, Hridi ;
Bi, Yingtao ;
Arslan, Ahmet Dirim ;
Clymer, Jessica ;
Alvarez, Angel A. ;
Goldman, Stewart ;
Cheng, Shi-Yuan ;
Nakano, Ichiro ;
Horbinski, Craig ;
Davuluri, Ramana V. ;
James, C. David ;
Platanias, Leonidas C. .
MOLECULAR CANCER RESEARCH, 2016, 14 (10) :984-993
[3]   Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity [J].
Binnewies, Mikhail ;
Mujal, Adriana M. ;
Pollack, Joshua L. ;
Combes, Alexis J. ;
Hardison, Emily A. ;
Barry, Kevin C. ;
Tsui, Jessica ;
Ruhland, Megan K. ;
Kersten, Kelly ;
Abushawish, Marwan A. ;
Spasic, Marko ;
Giurintano, Jonathan P. ;
Chan, Vincent ;
Daud, Adil, I ;
Ha, Patrick ;
Ye, Chun J. ;
Roberts, Edward W. ;
Krummel, Matthew F. .
CELL, 2019, 177 (03) :556-+
[4]   Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes [J].
Bousso, P ;
Robey, E .
NATURE IMMUNOLOGY, 2003, 4 (06) :579-585
[5]   Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma [J].
Chiu, Kuo-Chou ;
Lee, Chien-Hsing ;
Liu, Shyun-Yeu ;
Chou, Yu-Ting ;
Huang, Ren-Yeong ;
Huang, Shih-Ming ;
Shieh, Yi-Shing .
ORAL ONCOLOGY, 2015, 51 (07) :683-689
[6]   The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma [J].
Cichon, M. A. ;
Szentpetery, Z. ;
Caley, M. P. ;
Papadakis, E. S. ;
Mackenzie, I. C. ;
Brennan, C. H. ;
O'Toole, E. A. .
ONCOGENE, 2014, 33 (32) :4185-4192
[7]  
Fridell YWC, 1996, MOL CELL BIOL, V16, P135
[8]   Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (vol 49, 1148.e1, 2018) [J].
Garris, Christopher S. ;
Arlauckas, Sean P. ;
Kohler, Rainer H. ;
Trefny, Marcel P. ;
Garren, Seth ;
Piot, Cecile ;
Engblom, Camilla ;
Pfirschke, Christina ;
Siwicki, Marie ;
Gungabeesoon, Jeremy ;
Freeman, Gordon J. ;
Warren, Sarah E. ;
Ong, SuFey ;
Browning, Erica ;
Twitty, Christopher G. ;
Pierce, Robert H. ;
Le, Mai H. ;
Algazi, Alain P. ;
Daud, Adil I. ;
Pai, Sara I. ;
Zippelius, Alfred ;
Weissleder, Ralph ;
Pittet, Mikael J. .
IMMUNITY, 2022, 55 (09) :1749-1749
[9]   The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression [J].
Goyette, Marie-Anne ;
Duhamel, Stephanie ;
Aubert, Leo ;
Pelletier, Ariane ;
Savage, Paul ;
Thibault, Marie-Pier ;
Johnson, Radia Marie ;
Carmeliet, Peter ;
Basik, Mark ;
Gaboury, Louis ;
Muller, William J. ;
Park, Morag ;
Roux, Philippe P. ;
Gratton, Jean-Philippe ;
Cote, Jean-Francois .
CELL REPORTS, 2018, 23 (05) :1476-1490
[10]   Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models [J].
Guo, Zhiqiang ;
Li, Yan ;
Zhang, Dandan ;
Ma, Jiaying .
ONCOTARGET, 2017, 8 (52) :89761-89774